Grupo Cimed interested in KY brand
O Grupo Cimed estaria interessado na marca KY
Intel ID : 240645
| Synopsis |
|
Grupo Cimed, a Sao Paulo-based pharmaceutical company, is interested in acquiring Hypermarcas' KY brand, reported Valor Econômico on 15 September 2016. The Administrative Council for Economic Defense (Cade) approved the sale of Hypermarcas division for male condoms and intimate lubricants to Reckitt Benckiser Brasil, but imposed as a condition the sale of the KY brand in the country (see related transaction).
(content in portuguese)
O Grupo Cimed, empresa com sede em São Paulo, que atua na pesquisa e produção de medicamentos, estaria interessado na marca KY, da Hypermarcas, segundo publicou o Valor Econômico no dia 15 de setembro de 2016. O Conselho Administrativo de Defesa Econômica (Cade) aprovou a venda da divisão de preservativos masculinos e lubrificantes íntimos da Hypermarcas para a Reckitt Benckiser Brasil, mas impôs como condição a venda da marca KY no país (ver transação relacionada). |
|
||||
| Intel ID | 240645 | ||
| Value | ND | ||
| Native Currency |
Brazilian Real (BRL)
Exchange Rate:  |
||
|
Financial Data - Grupo Cimed
(31 Dec 2024) |
Revenue: EUR 295,87m EBITDA: EUR 47,39m Exchange Rate:
|
||
| Date |
|
||
| Country |  |
||
| Region | |||
| Continent | |
||
| Geography | |
||
| Subsector (Old TTR Sectors) |
|
||
| Type |
|
||
| Intel Grade |
|
||
| Source |
|
||
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Secondary Sectors (TTRSC) |
10.01.01 BPO/Outsource Services 10 Business Services / 10.01 Business & Professional Support Services 10.01.03 Distributors & Wholesalers (B2B) 10 Business Services / 10.01 Business & Professional Support Services 10.01.09 Intellectual Property Management Services 10 Business Services / 10.01 Business & Professional Support Services 15.05.08 Food & Beverage Retail 15 Consumer Products & Services / 15.05 Distribution & Retail 15.05.99 Other Distribution & Retail 15 Consumer Products & Services / 15.05 Distribution & Retail 15.07.07 Health Food & Supplements 15 Consumer Products & Services / 15.07 Food 25.04.03 Holding Companies / Financial Holding Companies 25 Financial Services / 25.04 Other Financial Services 30.01.01 Biopharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals 30.01.04 Specialty Pharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals 55.02.99 Other Chemicals 55 Raw Materials & Natural Resources / 55.02 Chemicals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Seller
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Secondary Sectors (TTRSC) |
30.01.01 Biopharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals 30.01.04 Specialty Pharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Mergers & Acquisitions
| Date | Target | Country | Buyer | Seller | VALUE (EURm) | Subsector | |||
|
|
|
|
|
|
|
|
 |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.